Irritant (e.g., Tear Gas, Etc.) Patents (Class 514/890)
-
Patent number: 9604891Abstract: As shown by the following reaction formula, disclosed is a fluorine-containing hydroxyaldehyde production method, including the step of obtaining a fluorine-containing hydroxyaldehyde represented by the general formula (1) by reacting a fluorine-containing ketone represented by the general formula (4) and an aldehyde represented by the general formula (5) in the presence of an organic base selected from a heterocyclic compound which contains a nitrogen atom in its ring or a tertiary amine. By this production method, it is possible to obtain the fluorine-containing hydroxyaldehyde in a high yield. Furthermore, it is possible to easily obtain in high yields a fluorine-containing propanediol, which is a derivative of this fluorine-containing hydroxyaldehyde, and a fluorine-containing alcohol monomer by using the same.Type: GrantFiled: March 17, 2015Date of Patent: March 28, 2017Assignee: Central Glass Company, LimitedInventors: Hitoshi Oomuro, Ryo Nadano, Masafumi Hirotsu
-
Patent number: 7544781Abstract: A process for producing a polypeptide, by reacting a peptide component (A) represented by formula (1) below with a peptide component (B) represented by formula (2) below and optionally a compound (C) represented by formula (3) below, to obtain said polypeptide: (1) X-(Pro-Y-Gly)n-OH, wherein: X represents H or the group HOOC—(CH2)m—CO— and m denotes an integer of 1 to 18, Y represents Pro or Hyp, and n denotes an integer of 1 to 20; (2) X-(Z)r—OH, wherein X represents H or the group HOOC—(CH2)m—CO— and m denotes an integer of 1 to 18, Z represents a peptide chain comprising 1 to 10 amino acid residue(s), and r denotes an integer of 1 to 20; and (3) H2N—R—NH2, wherein R represents a linear or branched alkylene group; and further wherein the ratio of the peptide component (A) relative to the peptide component (B) is 100/0 to 30/70 (mol %); provided that in the case where X represents the group HOOC—(CH2)m—CO— and m has the same meaning as defined above in formula (1) and/or (2), the amount of compouType: GrantFiled: July 26, 2007Date of Patent: June 9, 2009Assignee: PHG CorporationInventors: Masao Tanihara, Chikara Otsuki, Hiroshi Mikami, Hisao Kinoshita
-
Patent number: 7262275Abstract: The invention provides for a polypeptide, which is useful as a biomaterial and free from infection. The polypeptide comprises a peptide unit of formula (1), and optionally one or more units of formulae (2) to (3): (1) [—(OC—(CH2)m—CO)p-(Pro-Y-Gly)n-]a; (2) [—(OC—(CH2)m—CO)q-(Z)r-]b; and (3) [—HN—R—NH—]c, wherein “m” is 1-18 , “p” and “q” are identical or different, and each is 0 or 1 , “Y” is Pro or Hyp, and “n”1-20 ; “Z” is a peptide chain comprising 1-10 amino acids, “r”1-20 , and “R” is a linear or branched alkylene group; the molar ratio of “a” to “b”[a/b] is 100/0 to 30/70 ; when p=1 and q=0, c=a, when p=0 and q=1, c=b, when p=1 and q=1, c=a+b, and when p=0 and q=0, c=0; and the polypeptide shows a peak of molecular weight in a range from 1×104 to 100×104 in the molecular weight distribution.Type: GrantFiled: February 26, 2003Date of Patent: August 28, 2007Assignee: PHG CorporationInventors: Masao Tanihara, Chikara Otsuki, Hiroshi Mikami, Hisao Kinoshita
-
Patent number: 5217708Abstract: The present invention provides a capsicum containing lachrymator. The lachrymator comprises a nonflammable carrier and capsicum. The nonflammable carrier comprises propylene glycol, ethyl alcohol and water. In one preferred embodiment the lachrymator comprises about 0.3 percent by weight capsicum, about 14.7 percent by weight propylene glycol, about 35 percent by weight ethyl alcohol and about 50 percent by weight water.Type: GrantFiled: February 5, 1992Date of Patent: June 8, 1993Assignee: Defense Technology Corporation of AmericaInventor: Barry D. Pinkney
-
Patent number: 5026545Abstract: A pharmaceutical composition comprises an immune complex of an allergen and a purified antibody specific thereto, the allergen being selected from a specific subclass of antigen which causes immediate hypersensitivity that is mediated by IgE antibody, and a pharmacologically acceptable carrier or diluent. The method of using the compositions in the treatment of immediate hypersensitivity to the allergen is also described.Type: GrantFiled: September 20, 1989Date of Patent: June 25, 1991Assignees: Baxter International, Inc., International Institute of Cellular and Molecular PathologyInventors: Jean-Marie Saint-Remy, Philippe Lebrun, Serge Lebeque, Pierre L. Masson
-
Patent number: 5000347Abstract: A method for dispensing a protective fluid is set forth wherein a container is provided formed with a transparent storage portion threadedly receiving a cap thereto. The cap includes a lower end formed with a series of alignment bores for receiving tubular projections integrally formed coaxially upon an exterior surface of the portion of the cap to enable reciprocation of the upper portion relative to the lower portion. Positioning rods are positioned adjacent each of the bores to provide an abutment to enable effective alignment of the projections with the bores. The container is filled with a lemon juice concentrate, whereupon the container is prepared for transport by an individual. The upper portion of the cap may be rotated relative to the lower portion of the cap to permit reciprocation and projection of the lemon juice spray upon an attacker imposing oneself upon an individual.Type: GrantFiled: July 24, 1989Date of Patent: March 19, 1991Inventor: Anh T. H. Tran
-
Patent number: 4740371Abstract: In the treatment of allergy, desensitization is effected by administering the allergen in admixture with an antibody thereto, the antibody being present in a molar excess. The antibody is preferably one raised in the patient.Type: GrantFiled: September 17, 1984Date of Patent: April 26, 1988Assignee: International Institute of Cellular and Molecular PathologyInventors: Jean-Marie St. Remy, Philippe Lebrun, Serge Lebecque, Pierre Masson
-
Patent number: 4672122Abstract: New chemical compounds having the generic formula: ##STR1## wherein X is one equivalent of a monovalent or polyvalent anion; R and R' re methyl or ethyl radicals; R.sub.1, R.sub.1 ', R.sub.2, R.sub.2 ' are hydrogen or a methyl radical; and Z is a radical selected from methyl, ethyl, propyl, butyl, or pentyl and having utility as incapacitating agents and in munitions.Type: GrantFiled: January 21, 1972Date of Patent: June 9, 1987Assignee: The United States of America as represented by the Secretary of the ArmyInventors: Harold Z. Sommer, George E. Wicks, Jr.
-
Patent number: 4672123Abstract: New chemical compounds having the generic formula: ##STR1## wherein X is one equivalent of an anion selected from monovalent and pollent anions, and R,R' and Z are aliphatic radicals selected from the group consisting of ethyl, propyl, and butyl, with the provision that when Z is a radical selected from the group of octyl, dodecyl, and cyclohexyl, R,R' are selected from methyl and ethyl groups, and having utility as incapacitating agents and in munitions.Type: GrantFiled: April 28, 1967Date of Patent: June 9, 1987Assignee: The United States of America as represented by the Secretary of the ArmyInventors: Harold Z. Sommer, George E. Wicks, Jr.
-
Patent number: 4598096Abstract: A method of safely forcing the egress of human beings from a zone by supplying the zone with an irritating amount of 1-methoxy-1,3,5-cycloheptatriene.Type: GrantFiled: November 6, 1981Date of Patent: July 1, 1986Inventor: George A. Grant